Picture of Galera Therapeutics logo

GRTX Galera Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSuper Stock

Brief: Galera Therapeutics Reports Q4 And FY2020 Financial Results

March 11 (Reuters) - Galera Therapeutics Inc  GRTX.O :
    * GALERA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2020
FINANCIAL RESULTS AND RECENT ACCOMPLISHMENTS
    * Q4 LOSS PER SHARE $0.80
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.71 -- REFINITIV IBES
DATA
    * GALERA - EXPECTS EXISTING CASH, CASH EQUIVALENTS &
SHORT-TERM
INVESTMENTS WILL ENABLE TO FUND OPERATING EXPENSES & CAPEX
REQUIREMENTS INTO H2 2022

Source text for Eikon:  ID:nGNX9fJN6x 
Further company coverage:  GRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Galera Therapeutics

See all news